Patents by Inventor Elena Losi

Elena Losi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particle size reduction of an antimuscarinic compound
    Patent number: 9889094
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: February 13, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene Pasquali, Andrea Casazza, Elena Losi, Mark Saunders
  • PARTICLE SIZE REDUCTION OF AN ANTIMUSCARINIC COMPOUND
    Publication number: 20160279066
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Andrea CASAZZA, Elena LOSI, Mark SAUNDERS
  • Particle size reduction of an antimuscarinic compound
    Patent number: 9393202
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: July 19, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A
    Inventors: Irene Pasquali, Andrea Casazza, Elena Losi, Mark Saunders
  • Pharmaceutical formulation comprising a phosphodiesterase inhibitor
    Patent number: 9358224
    Abstract: Pharmaceutical formulations to be administered by pressurized metered dose inhalers (pMDIs), comprising a compound of general formula (I) may be used for the treatment and/or prevention of inflammatory or obstructive airway diseases.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: June 7, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro Bonelli, Elena Losi, Enrico Zambelli
  • PARTICLE SIZE REDUCTION OF AN ANTIMUSCARINIC COMPOUND
    Publication number: 20140322142
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 30, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Andrea Casazza, Elena Losi, Mark Saunders
  • PHARMACEUTICAL FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20120034172
    Abstract: Pharmaceutical formulations to be administered by pressurized metered dose inhalers (pMDIs), comprising a compound of general formula (I) may be used for the treatment and/or prevention of inflammatory or obstructive airway diseases.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 9, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Elena Losi, Enrico Zambelli